About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Research Group on Status Epilepticus and Acute Seizures is a young and emerging team, consolidated in national and international clinical research and in the comprehensive and multidisciplinary approach to epilepsy. The scientific challenge of the group is based on understanding, improving and strengthening knowledge about the different fields of epilepsy and how to help solve problems related to epileptic seizures and their consequences.
Among the different projects of the group, it is worth mentioning the search for new biomarkers related to the mechanisms of epileptogenesis, obtaining tools and biomarkers to help diagnose status epilepticus and predict its prognosis, the acquisition of neuroimaging parameters and their relationship with the cognitive status of patients, and other studies to accelerate the diagnostic processes and optimize the therapeutic management of patients with drug-resistant epilepsy.
IP: LAURA ABRAIRA DEL FRESNO Collaborators: Anna Penalba Morenilla, Manuel Toledo Argany, Anna Sánchez Corral, Elena Fonseca Hernandez, Daniel Campos Fernández, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Fundación Eugenio Rodríguez Pascual Funding: 24990 Reference: FERP-2022-FERP-2022-1 Duration: 01/01/2023 - 31/12/2024
IP: Estevo Santamarina Pérez Collaborators: Javier Sánchez López, Manuel Toledo Argany, LAURA ABRAIRA DEL FRESNO, Elena Fonseca Hernandez, Enric Bellido Castillo, Daniel Campos Fernández, Manuel Quintana Luque Funding agency: AGAUR Funding: 0.01 Reference: 2021 SGR 00047 Duration: 01/01/2022 - 31/12/2024
IP: Estevo Santamarina Pérez Collaborators: Daniel Campos Fernández, Judit Álvarez González Funding agency: Fundació Institut de Recerca HUVH Funding: 35000 Reference: HUVH/BPFSE_CM/2022/CAMPOS Duration: 08/06/2022 - 07/06/2023
IP: Elena Fonseca Hernandez Collaborators: Judit Álvarez González Funding agency: Hospital Universitari Vall d'Hebron Funding: 35000 Reference: HUVH/AULA_VH/2022/LALLANA Duration: 01/07/2022 - 30/06/2023
PMID: 34687043 Journal: ACTA NEUROLOGICA SCANDINAVICA Year: 2022 Reference: Acta Neurol Scand. 2022 Feb;145(2):239-248. doi: 10.1111/ane.13543. Epub 2021 Oct 22. Impact factor: 3.209 Publication type: Paper in international publication Authors: Fonseca, Elena; Quintana, Manuel; Seijo-Raposo, Ivan; Ortiz de Zarate, Zurine; Abraira, Laura; Santamarina, Estevo; Toledo, Manuel; Alvarez-Sabin, Jose et al. DOI: 10.1111/ane.13543
PMID: 35152335 Journal: JOURNAL OF NEUROLOGY Year: 2022 Reference: J Neurol. 2022 Jul;269(7):3761-3769. doi: 10.1007/s00415-022-11005-1. Epub 2022 Feb 13. Impact factor: 4.849 Publication type: Paper in international publication Authors: Coscojuela, P; Fonseca, E; Quintana, M; Sarria-Estrada, S; Santamarina, E; Abraira, L; Sueiras, M; Thonon, V; Alvarez-Sabin, J; Toledo, M et al. DOI: 10.1007/s00415-022-11005-1
PMID: 35030636 Journal: NEUROPEDIATRICS Year: 2022 Reference: Neuropediatrics. 2022 Apr;53(2):147-148. doi: 10.1055/a-1740-9649. Epub 2022 Jan 14. Impact factor: 1.947 Publication type: Paper in international publication Authors: Gomez-Andres, David, Armangue, Thais, Sanchez-Montanez, Angel, Ortiz de Zarate Caballero, Zurine, Felipe-Rucian, Ana et al. DOI: 10.1055/a-1740-9649
PMID: 33875301 Journal: NEUROLOGIA Year: 2021 Reference: Neurologia (Engl Ed). 2021 Apr 16. pii: S0213-4853(21)00053-0. doi: 10.1016/j.nrl.2021.02.014. Impact factor: 3.109 Publication type: Paper in national publication Authors: Llaurado, A, Quintana, M, Fonseca, E, Abraira, L, Toledo, M, Requena, M, Olive, M, Ballve, A, Campos, D, Sueiras, M et al. DOI: 10.1016/j.nrl.2021.02.014
PhD student: Manuel Quintana Luque Director/s: Manuel Toledo Argany, José Alvarez Sabin University: Year: 2022
PhD student: Elena Fonseca Hernandez Director/s: José Alvarez Sabin University: Universitat Autònoma de Barcelona Year: 2021
